Orwin John A

Orwin John A is listed in filings as Director at Travere Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including 24 public disclosures. Recent filings connect the profile to Travere Therapeutics, Inc. (TVTX), AnaptysBio, Inc. (ANAB), and CARGO Therapeutics, Inc. Common Stock (CRGX). The current snapshot covers public activity from Sep 17, 2024 to May 21, 2026. Reported amounts are shown as $507.1K to $349.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.